aTyr Pharma | LIFE - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Ardelyx USD -32.79M 37.89M 2026-03
aTyr Pharma USD -128K 24.6M 2026-03
Biogen USD -243.8M 758.1M 2026-06
Bristol-Myers Squibb USD 299M 3.07B 2026-06
Cipla INR 8.88B 2.74B 2026-06
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD -9.02M 65.06M 2026-03
CSL USD 2.64B 1.97B 2025-12
Curis USD -11.52M 3.64M 2026-03
GlaxoSmithKline GBP 2.6B 312M 2026-06
Grifols EUR 320.55M 91.01M 2025-12
Lakefront Biotherapeutics EUR -43.51M 20.19M 2026-06
Novartis USD 4.75B 515M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
United Therapeutics USD 330.8M 5M 2026-06